Philippa Lewis, founder of Elementum was an official mentor for the ATC. One of the companies mentored, Vectus, was announced as the winner of the Medtech Life science category.
Vectus Biosystems Limited holds patents around the Vasoactive Intestinal Peptide (VIP) and its fragments as a therapeutic candidate to treat cardiovascular fibrosis and systolic blood pressure.
Vectus Biosystems Limited intends to remain a research and development company, and license its current and future technologies.
About ATC awards - Australian high-tech companies with global potential were celebrated at a gala dinner in Sydney on 2 November. The event showcased technology companies delivering solutions across all of the Country’s high growth sectors including energy, resources, mining, agriculture, cities and medtech.
